LIN-2006

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameLIN-2006
Drug Alias NameLIN-2006
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionCytomegalovirus (CMV) envelope glycoprotein H inhibitors
TargetsCytomegalovirus (CMV) envelope glycoprotein H
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLinnuo (Shanghai) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLinnuo (Shanghai) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A